In the article titled "Association of Nuclear Factor-Erythroid 2-Related Factor 2, Thioredoxin Interacting Protein, and Heme Oxygenase-1 Gene Polymorphisms with Diabetes and Obesity in Mexican Patients," \[[@B1]\] typing errors were found after subsequent analyses of the entire dataset. These issues were raised to the attention of the original authors by Drs. Meza-Espinoza, Leal-Ugarte, and Peralta-Leal of the Universidad Autónoma de Tamaulipas. The allelic frequencies were added and the corrected data are shown in italics in Tables [2](#tab1){ref-type="table"}, [3](#tab2){ref-type="table"}, and [4](#tab3){ref-type="table"}.

It is important to remark that the model (recessive for allele T, [Table 4](#tab3){ref-type="table"}) was calculated taking in count that CC + CT = 0. When CC is considered as the risk allele the OR increases to 2.4 (CI: 1.28--4.64, *P* = 0.006) under a dominant model (CC + CT = 1 versus TT = 0). This reveals that the TT genotype in this study shows a protective factor against obesity and the genotype CC could be considered as the risk factor for obesity, as was stated in the original article.

The last paragraph of Section 3 should be "CC carriers had higher glucose levels in comparison with CA + *AA* carriers when genotype was compared as dominant model."

Finally, in Section 4 (Discussion) when Wang et al. \[7\] is cited, the correct statement is the following:

"Individuals with CC genotype had lower total antioxidant capacity, glutathione levels, superoxide dismutase, catalase, and glutathione peroxidase activities as well as lower homeostasis model assessment of *β*-cell function index (HOMA-*β*) in comparison with individuals with the AA genotype."

###### 

Genotype and allele frequencies of the polymorphisms studied in diabetic patients and controls.

  ------------------------------------------------------------------------------------------------------------
  Gene/polymorphism   Genotypes       Diabetes         Controls               OR (95% CI)   *P*   *P* of HWE
  ------------------- --------------- ---------------- ---------------------- ------------- ----- ------------
  TXNIP \             CC              345 (55.4)       528 (54.5)             Reference           0.880
  rs7211                                                                                          

  CT                  239 (38.4)      376 (38.8)       *0.97 (0.78--1.2)*     *0.798*             

  TT                  39 (6.2)        65 (6.7)         *0.92 (0.60--1.39)*    *0.690*             

  *C*                 *939 (74.6)*    *1432 (73.9)*    *Reference*                                

  *T*                 *317 (25.4)*    *506 (26.1)*     *0.966 (1.82--1.37)*   *0.674*             

                                                                                                  

  NQO1 \              CC              216 (34.7)       327 (33)               Reference           0.406
  rs1800566                                                                                       

  CT                  288 (46.2)      483 (48.6)       0.90 (0.7--1.1)        0.373               

  TT                  119 (19.1)      183 (18.4)       0.98 (0.7--1.3)        0.915               

  *C*                 *720 (57.8)*    *1137 (57.25)*   *Reference*                                

  *T*                 *526 (42.2)*    *849 (42.75)*    *0.98 (0.85--1.13)*    *0.765*             

                                                                                                  

  HMOX-1 \            AA              269 (43.8)       413 (43.2)             Reference           0.625
  rs2071749                                                                                       

  AG                  267 (43.5)      417 (43.6)       *0.98 (0.79--1.2)*     *0.877*             

  GG                  78 (12.7)       126 (13.2)       *0.95 (0.69--1.3)*     *0.757*             

  *A*                 *805 (65.5)*    *1243 (65)*      *Reference*                                

  *G*                 *423 (34.5)*    *669 (35)*       *0.97 (0.84--1.13)*    *0.755*             

                                                                                                  

  NRF2 \              CC              210 (33.6)       301 (30.3)             Reference           0.092
  rs2364723                                                                                       

  CG                  286 (*45.7*)    471 (47.5)       0.87 (0.7--1.1)        0.236               

  GG                  129 (20.6)      220 (22.2)       0.84 (0.63--1.1)       0.223               

  *C*                 *706 (56.5)*    *1073 (54)*      *Reference*                                

  *G*                 *544 (43.5)*    *911 (46)*       *0.91 (0.79--1.05)*    *0.182*             

                                                                                                  

  NRF2 \              CC              407 (65.3)       618 (62.5)             Reference           0.281
  rs6721961                                                                                       

  CA                  189 (30.4)      317 (32)         0.90 (0.7--1.1)        0.374               

  AA                  27 (4.3)        54 (5.5)         0.76 (0.5--1.2)        0.259               

  *C*                 *1003 (80.5)*   *1553 (78.5)*    *Reference*                                

  *A*                 *243 (19.5)*    *425 (21.5)*     *0.88 (0.74--1.05)*    *0.176*             
  ------------------------------------------------------------------------------------------------------------

CI, confidence interval; HWE, Hardy-Weinberg equilibrium; HMOX-1, heme oxygenase 1; NQO1, NAD(P)H quinone oxidoreductase 1; NRF2, nuclear factor-erythroid 2- (NF-E2-) related factor 2; OR, odds ratio; and TXNIP, thioredoxin-interacting protein.

###### 

Genotype and allele frequencies of the polymorphisms studied in obese and nonobese subjects.

  --------------------------------------------------------------------------------------------
  Gene/polymorphism   Genotype       Obesity         No obesity            OR (95% CI)   *P*
  ------------------- -------------- --------------- --------------------- ------------- -----
  TRXNIP \            CC             350 (56.6)      523 (53.7)            Reference      
  rs7211                                                                                 

  CT                  239 (38.7)     376 (38.6)      *0.95 (0.77--1.17)*   *0.633*       

  TT                  29 (4.7)       75 (7.7)        *0.57 (0.37--0.9)*    *0.017*       

  *C*                 *239 (76)*     *1422 (73)*     *Reference*                         

  *T*                 *297 (24)*     *526 (27)*      *0.85 (0.72--1)*      *0.061*       

                                                                                         

  NQO1 \              CC             212 (34.2)      331 (33.3)            Reference      
  rs1800566                                                                              

  CT                  302 (48.8)     469 (47)        1 (0.8--1.25)         0.963         

  TT                  106 (17)       196 (19.7)      0.84 (0.6--1.1)       0.257         

  *C*                 *726 (58.5)*   *1131 (56.8)*   *Reference*                         

  *T*                 *514 (41.5)*   *561 (43.2)*    *0.93 (0.8--1.07)*    *0.322*       

                                                                                         

  HMOX-1 \            AA             261 (40)        419 (45.7)            Reference      
  rs2071749                                                                              

  AG                  305 (46.9)     378 (41.3)      1.3 (1--1.6)          0.019         

  GG                  85 (13.1)      119 (13)        1.1 (0.8--1.5)        *0.399*       

  *G*                 *827 (63.5)*   *1216 (66.4)*   *Reference*                         

  *A*                 *475 (36.5)*   *616 (36.6)*    *1.13 (0.97--1.31)*   *0.097*       

                                                                                         

  NRF2 \              CC             194 (31)        317 (32)              Reference      
  rs2364723                                                                              

  CG                  300 (48)       457 (46)        1.1 (0.85--1.35)      0.551         

  GG                  131 (21)       *218* (22)      0.98 (0.7--1.3)       0.899         

  *C*                 *688 (55)*     *1091 (55)*     *Reference*                         

  *G*                 *562 (45)*     *893 (45)*      *0.99 (0.86--1.15)*   *0.699*       

                                                                                         

  NRF2 \              CC             390 (63.1)      635 (63.9)            Reference      
  rs6721961                                                                              

  CA                  195 (31.6)     311 (31.3)      1 (0.8--1.3)          0.853         

  AA                  33 (5.3)       48 (4.8)        1.1 (0.7--1.7)        0.631         

  *C*                 *975 (78.9)*   *1581 (79.5)*   *Reference*                         

  *A*                 *261 (21.1)*   *407 (20.5)*    *1.04 (0.87--1.23)*   *0.661*       
  --------------------------------------------------------------------------------------------

TXNIP, thioredoxin-interacting protein; NQO1, NAD(P)H quinone oxidoreductase 1; HMOX-1, heme oxygenase 1; NRF2, nuclear factor-erythroid 2- (NF-E2-) related factor 2.

###### 

Genotype frequency of the rs7211 polymorphism in subjects without diabetes and women.

                               Obese          Nonobese       Crude OR (95% CI)    *P*       Adjusted^a^ OR (95% CI)   *P*
  ---------------------------- -------------- -------------- -------------------- --------- ------------------------- ---------
  Nondiabetic                                                                                                          
   CC                          189 (56.6)     339 (53.4)     Reference                      Reference                  
   CT                          133 *(39.8)*   *243 (38.3)*   *0.98 (0.75--1.3)*   *0.896*   1 (0.77--1.4)             0.863
   TT                          *12 (3.6)*     *53 (8.3)*     *0.4 (0.21--0.77)*   *0.007*   0.3 (0.15--0.7)           0.003
   CC + CT = 0 versus TT = 1   *322 (96.4)*   *582 (91.5)*   *0.4 (0.21--0.76)*   *0.006*   *0.39 (0.18--0.8)*        *0.014*
  Women                                                                                                                
   CC                          197 (59)       259 (51)       Reference                      Reference                  
   CT                          118 (36)       203 (40)       0.7 (0.6--1)         0.072     0.9 (0.6--1.2)            0.418
   TT                          17 (5)         47 (9)         0.5 (0.26--0.85)     0.013     0.5 (0.25--0.96)          0.04
   CT + TT                     135 (41)       250 (49)       0.70 (0.5--0.9)      0.016     0.7 (0.5--0.96)           0.028

CI, confidence interval; OR, odds ratio.

^a^Obesity in logistic regression was adjusted by age, gender (except in women model), glucose, triglycerides, LDL-C, and HDL-C levels.
